Literature DB >> 12883693

The putative serine/threonine kinase gene STK15 on chromosome 20q13.2 is amplified in human gliomas.

Wilfried Reichardt1, Volker Jung, Christian Brunner, Alexandra Klein, Silke Wemmert, Bernd F M Romeike, Klaus D Zang, Steffi Urbschat.   

Abstract

Searching for amplifications in low grade and high grade gliomas we observed an interesting correlation between the recurrence and progression of astrocytic low grade gliomas and the amplification of the STK15 gene located in the chromosomal region 20q13. Chromosome copy gains in this region have been reported previously in astrocytic gliomas and glioma cell lines and in many cancer types including breast, colorectal and ovarian cancers. The putative serine/threonine kinase STK15 has been reported to be amplified and overexpressed in breast cancer cell lines and colorectal cancer. Another candidate gene located in this region is PTPN1, a protein tyrosine phosphatase non-receptor type 1 that might play a role in cell cycle control. We used comparative PCR for quantitative DNA analysis to search for STK15 and PTPN1 amplification in gliomas previously characterized by CGH. Five out of 16 tumors (31%) of different WHO grade (1x grade II, 1x grade III, 3x grade IV) showed DNA amplification of STK15 whereas we did not detect amplification of PTPN1. We hypothesize that amplification of the STK15 gene may be a non-random genetic alteration in human gliomas playing a role in the genetic pathways of tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12883693

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  18 in total

1.  Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas.

Authors:  Norman L Lehman; James P O'Donnell; Lisa J Whiteley; Robert T Stapp; Trang D Lehman; Kathleen M Roszka; Lonni R Schultz; Caitlin J Williams; Tom Mikkelsen; Stephen L Brown; Jeffrey A Ecsedy; Laila M Poisson
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

2.  A combinatorial radiographic phenotype may stratify patient survival and be associated with invasion and proliferation characteristics in glioblastoma.

Authors:  Arvind Rao; Ganesh Rao; David A Gutman; Adam E Flanders; Scott N Hwang; Daniel L Rubin; Rivka R Colen; Pascal O Zinn; Rajan Jain; Max Wintermark; Justin S Kirby; C Carl Jaffe; John Freymann
Journal:  J Neurosurg       Date:  2015-10-16       Impact factor: 5.115

Review 3.  The potential role of Aurora kinase inhibitors in haematological malignancies.

Authors:  Sherif S Farag
Journal:  Br J Haematol       Date:  2011-10-08       Impact factor: 6.998

4.  Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma.

Authors:  C Kurokawa; H Geekiyanage; C Allen; I Iankov; M Schroeder; B Carlson; K Bakken; J Sarkaria; J A Ecsedy; A D'Assoro; B Friday; E Galanis
Journal:  J Neurooncol       Date:  2016-11-05       Impact factor: 4.130

5.  Pdx-1-driven overexpression of aurora a kinase induces mild ductal dysplasia of pancreatic ducts near islets in transgenic mice.

Authors:  Steven L Warner; Ruben M Muñoz; David J Bearss; Paul Grippo; Haiyong Han; Daniel D Von Hoff
Journal:  Pancreas       Date:  2008-10       Impact factor: 3.327

6.  Transcriptional regulation of serine/threonine kinase-15 (STK15) expression by hypoxia and HIF-1.

Authors:  Alexandra Klein; Daniela Flügel; Thomas Kietzmann
Journal:  Mol Biol Cell       Date:  2008-06-18       Impact factor: 4.138

7.  Differential expression of centrosomal proteins at different stages of human glioma.

Authors:  Joon-Khim Loh; Ann-Shung Lieu; Chia-Hua Chou; Fang-Yi Lin; Chia-Hung Wu; Sheng-Long Howng; Chung-Ching Chio; Yi-Ren Hong
Journal:  BMC Cancer       Date:  2010-06-09       Impact factor: 4.430

8.  Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway.

Authors:  Ya-Shih Tseng; Jenq-Chang Lee; Chi-Ying F Huang; Hsiao-Sheng Liu
Journal:  BMC Cancer       Date:  2009-12-12       Impact factor: 4.430

Review 9.  Protein tyrosine phosphatases in glioma biology.

Authors:  Anna C Navis; Monique van den Eijnden; Jan T G Schepens; Rob Hooft van Huijsduijnen; Pieter Wesseling; Wiljan J A J Hendriks
Journal:  Acta Neuropathol       Date:  2009-11-21       Impact factor: 17.088

10.  A cancer-associated aurora A mutant is mislocalized and misregulated due to loss of interaction with TPX2.

Authors:  Rachel Ann Bibby; Chan Tang; Amir Faisal; Konstantinos Drosopoulos; Steven Lubbe; Richard Houlston; Richard Bayliss; Spiros Linardopoulos
Journal:  J Biol Chem       Date:  2009-10-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.